|1.||Salcedo, Margarita: 1 article (06/2011)|
|2.||Baritaki, Stavroula: 1 article (06/2011)|
|3.||Spandidos, Demetrios A: 1 article (06/2011)|
|4.||Malaponte, Graziella: 1 article (06/2011)|
|5.||Bonavida, Benjamin: 1 article (06/2011)|
|6.||Militello, Loredana: 1 article (06/2011)|
|1.||B-Cell Lymphoma (Lymphoma, B Cell)
06/01/2011 - "PTEN silencing in Ramos cells pretreated with LFB-R603 and TRAIL inhibited TRAIL apoptosis; thus, demonstrating that PTEN induction by LFB-R603 has a direct role in tumor cell sensitization to TRAIL apoptosis. "
06/01/2011 - "Hence, we hypothesized that LFB-R603 may signal the tumor cells and modify intracellular survival/anti-apoptotic pathways. "
06/01/2011 - "Further, the findings suggest that LFB-R603 may sensitize tumor cells to various apoptotic stimuli including cytotoxic ligands such as TRAIL and chemotherapeutic drugs."
06/01/2011 - "We examined several experimental designs for the biological anti-tumor activity of LFB-R603 as well as its sensitizing activity to apoptosis in resistant non-Hodgin's B-cell lymphoma (B-NHL) in comparison to rituximab. "